Search Results 461-470 of 16821 for Antagonist

1. Chronic Nausea And Vomiting In Patients With Normal Gastric Emptying Using The Enterra® Therapy System - Mayo Clinic

   ... antagonists, dopamine type 2 receptor antagonists, anticholinergics, neurokinin receptor antagonists; Medically stable, in the opinion of the investigator ...

2. Functioning gonadotroph macroadenoma causing ovarian hyperstimulation: A case from the endocrine teaching clinics

   While dopamine agonists and somatostatin analogues have decreased ovarian volumes and gonadotropin secretion in a limited number of cases, Gn-RH antagonists ...

3. Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study - Mayo Clinic

   On stable oral PAH disease-specific background therapy of oral or inhaled therapies (any combination of an endothelin receptor antagonist, phosphodiesterase ...

4. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

   No requirement for constant administration of proton pump inhibitor, H2 antagonist, or pancreatic enzymes. Willing to limit daily alcohol intake to the ...

5. Mayo Clinic Q and A: Treatment options for migraine

   Now two new calcitonin gene-related peptide receptor antagonists are available for as-needed treatment of migraine — and they don't narrow blood vessels. They ...

6. A Study To Evaluate The Safety And Tolerability Of TreT In Subjects With PAH Currently Using Tyvaso - Mayo Clinic

   If currently receiving other approved background therapy (e.g., endothelin receptor antagonist or phosphodiesterase type 5 inhibitor or both), the subject ...

7. Ovarian Axis Hormones and Adrenal Androgens and Measurements of Satiation, Postprandial Satiety, and Hunger in Pre- and Post-menopausal Women - Mayo Clinic

   Use of any drug that can affect estrogen production or signaling (e.g., GnRH agonists and antagonists, estrogen receptor modulators, etc.). Use of systemic ...

8. B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

   Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

9. Publications - Ying-Chun Lo, M.D., Ph.D. - Mayo Clinic

   A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy Computational and Structural Biotechnology Journal. 2015; 8(13): 265-272 ...

10. Telomere Length and Telomerase Activity Effect on In Vitro Outcomes - Mayo Clinic

    Undergoing autologous IVF planning for monitoring at Mayo Clinic Rochester with an antagonist or long luteal protocol, planned fresh embryo transfer, ...